nodes	percent_of_prediction	percent_of_DWPC	metapath
Rilpivirine—SLCO1B3—Mycophenolate mofetil—systemic lupus erythematosus	0.102	0.121	CbGbCtD
Rilpivirine—ABCG2—Leflunomide—systemic lupus erythematosus	0.0765	0.0906	CbGbCtD
Rilpivirine—SLCO1B1—Mycophenolate mofetil—systemic lupus erythematosus	0.0595	0.0705	CbGbCtD
Rilpivirine—ABCG2—Mycophenolate mofetil—systemic lupus erythematosus	0.0472	0.056	CbGbCtD
Rilpivirine—SLCO1B1—Cyclosporine—systemic lupus erythematosus	0.0451	0.0534	CbGbCtD
Rilpivirine—SLCO1B3—Methotrexate—systemic lupus erythematosus	0.041	0.0485	CbGbCtD
Rilpivirine—ABCG2—Hydrocortisone—systemic lupus erythematosus	0.0379	0.0449	CbGbCtD
Rilpivirine—ABCG2—Cyclosporine—systemic lupus erythematosus	0.0358	0.0424	CbGbCtD
Rilpivirine—CYP1A2—Leflunomide—systemic lupus erythematosus	0.0315	0.0374	CbGbCtD
Rilpivirine—CYP2C19—Dapsone—systemic lupus erythematosus	0.0243	0.0289	CbGbCtD
Rilpivirine—SLCO1B1—Methotrexate—systemic lupus erythematosus	0.0239	0.0283	CbGbCtD
Rilpivirine—ABCG2—Dexamethasone—systemic lupus erythematosus	0.0236	0.0279	CbGbCtD
Rilpivirine—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0225	0.0266	CbGbCtD
Rilpivirine—ABCG2—Methotrexate—systemic lupus erythematosus	0.0189	0.0225	CbGbCtD
Rilpivirine—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.017	0.0202	CbGbCtD
Rilpivirine—CYP2C19—Prednisone—systemic lupus erythematosus	0.0169	0.02	CbGbCtD
Rilpivirine—CYP2B6—Dexamethasone—systemic lupus erythematosus	0.0166	0.0197	CbGbCtD
Rilpivirine—CYP2C19—Cyclosporine—systemic lupus erythematosus	0.016	0.019	CbGbCtD
Rilpivirine—ABCB1—Betamethasone—systemic lupus erythematosus	0.0146	0.0173	CbGbCtD
Rilpivirine—ABCB1—Prednisolone—systemic lupus erythematosus	0.0144	0.0171	CbGbCtD
Rilpivirine—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.0137	0.0162	CbGbCtD
Rilpivirine—ABCB1—Prednisone—systemic lupus erythematosus	0.0136	0.0161	CbGbCtD
Rilpivirine—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0135	0.016	CbGbCtD
Rilpivirine—ABCB1—Cyclosporine—systemic lupus erythematosus	0.0129	0.0153	CbGbCtD
Rilpivirine—CYP3A4—Dapsone—systemic lupus erythematosus	0.0118	0.014	CbGbCtD
Rilpivirine—CYP2C19—Dexamethasone—systemic lupus erythematosus	0.0105	0.0125	CbGbCtD
Rilpivirine—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0102	0.0121	CbGbCtD
Rilpivirine—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0102	0.0121	CbGbCtD
Rilpivirine—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00876	0.0104	CbGbCtD
Rilpivirine—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00864	0.0102	CbGbCtD
Rilpivirine—ABCB1—Dexamethasone—systemic lupus erythematosus	0.0085	0.0101	CbGbCtD
Rilpivirine—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00819	0.00971	CbGbCtD
Rilpivirine—CYP3A4—Prednisone—systemic lupus erythematosus	0.00816	0.00967	CbGbCtD
Rilpivirine—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00773	0.00917	CbGbCtD
Rilpivirine—ABCB1—Methotrexate—systemic lupus erythematosus	0.00683	0.0081	CbGbCtD
Rilpivirine—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00509	0.00604	CbGbCtD
Rilpivirine—Pazopanib—LYN—systemic lupus erythematosus	0.00505	0.513	CrCbGaD
Rilpivirine—Pazopanib—SH2B3—systemic lupus erythematosus	0.00479	0.487	CrCbGaD
Rilpivirine—CYP2C19—urine—systemic lupus erythematosus	0.00211	0.115	CbGeAlD
Rilpivirine—CYP1A2—urine—systemic lupus erythematosus	0.00173	0.0942	CbGeAlD
Rilpivirine—SLCO1B1—blood plasma—systemic lupus erythematosus	0.00169	0.0924	CbGeAlD
Rilpivirine—CYP3A4—urine—systemic lupus erythematosus	0.00125	0.0682	CbGeAlD
Rilpivirine—CYP2C19—blood plasma—systemic lupus erythematosus	0.0011	0.0602	CbGeAlD
Rilpivirine—SLCO1B3—lung—systemic lupus erythematosus	0.00094	0.0513	CbGeAlD
Rilpivirine—CYP1A2—blood plasma—systemic lupus erythematosus	0.000901	0.0491	CbGeAlD
Rilpivirine—CYP2B6—blood plasma—systemic lupus erythematosus	0.000864	0.0471	CbGeAlD
Rilpivirine—SLCO1B1—kidney—systemic lupus erythematosus	0.000768	0.0419	CbGeAlD
Rilpivirine—NR1I2—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000765	0.0484	CbGpPWpGaD
Rilpivirine—CYP3A4—blood plasma—systemic lupus erythematosus	0.000652	0.0356	CbGeAlD
Rilpivirine—CYP1A2—Arylamine metabolism—NAT2—systemic lupus erythematosus	0.000519	0.0329	CbGpPWpGaD
Rilpivirine—Abdominal pain—Dapsone—systemic lupus erythematosus	0.000515	0.00459	CcSEcCtD
Rilpivirine—Blood creatinine increased—Cyclosporine—systemic lupus erythematosus	0.000512	0.00456	CcSEcCtD
Rilpivirine—Blood creatinine increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000499	0.00445	CcSEcCtD
Rilpivirine—SLCO1B3—Recycling of bile acids and salts—RXRA—systemic lupus erythematosus	0.000495	0.0313	CbGpPWpGaD
Rilpivirine—Urinary tract disorder—Leflunomide—systemic lupus erythematosus	0.000484	0.00431	CcSEcCtD
Rilpivirine—ABCG2—nephron tubule—systemic lupus erythematosus	0.000483	0.0263	CbGeAlD
Rilpivirine—Urethral disorder—Leflunomide—systemic lupus erythematosus	0.00048	0.00428	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Mycophenolate mofetil—systemic lupus erythematosus	0.00048	0.00427	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Mycophenolate mofetil—systemic lupus erythematosus	0.00047	0.00419	CcSEcCtD
Rilpivirine—Immune system disorder—Azathioprine—systemic lupus erythematosus	0.000468	0.00417	CcSEcCtD
Rilpivirine—ABCB1—blood plasma—systemic lupus erythematosus	0.000462	0.0252	CbGeAlD
Rilpivirine—Abdominal discomfort—Cyclosporine—systemic lupus erythematosus	0.000453	0.00403	CcSEcCtD
Rilpivirine—CYP2B6—nephron tubule—systemic lupus erythematosus	0.000446	0.0243	CbGeAlD
Rilpivirine—NR1I2—Nuclear Receptors—RXRA—systemic lupus erythematosus	0.000444	0.0281	CbGpPWpGaD
Rilpivirine—Immune system disorder—Leflunomide—systemic lupus erythematosus	0.000442	0.00394	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000439	0.0278	CbGpPWpGaD
Rilpivirine—Mental disorder—Leflunomide—systemic lupus erythematosus	0.000429	0.00382	CcSEcCtD
Rilpivirine—Inflammation—Methotrexate—systemic lupus erythematosus	0.000429	0.00382	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Hydrocortisone—systemic lupus erythematosus	0.000428	0.00381	CcSEcCtD
Rilpivirine—Malnutrition—Leflunomide—systemic lupus erythematosus	0.000426	0.0038	CcSEcCtD
Rilpivirine—Depression—Cyclosporine—systemic lupus erythematosus	0.00042	0.00374	CcSEcCtD
Rilpivirine—CYP2B6—skin of body—systemic lupus erythematosus	0.000415	0.0226	CbGeAlD
Rilpivirine—Vomiting—Dapsone—systemic lupus erythematosus	0.000414	0.00369	CcSEcCtD
Rilpivirine—Renal failure—Cyclosporine—systemic lupus erythematosus	0.000414	0.00369	CcSEcCtD
Rilpivirine—Depression—Mycophenolate mofetil—systemic lupus erythematosus	0.000409	0.00365	CcSEcCtD
Rilpivirine—Headache—Dapsone—systemic lupus erythematosus	0.000408	0.00364	CcSEcCtD
Rilpivirine—Renal failure—Mycophenolate mofetil—systemic lupus erythematosus	0.000404	0.0036	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Methylprednisolone—systemic lupus erythematosus	0.000402	0.00358	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptors—VDR—systemic lupus erythematosus	0.000402	0.0254	CbGpPWpGaD
Rilpivirine—Hepatobiliary disease—Cyclosporine—systemic lupus erythematosus	0.000398	0.00355	CcSEcCtD
Rilpivirine—CYP2B6—kidney—systemic lupus erythematosus	0.000392	0.0214	CbGeAlD
Rilpivirine—Hepatobiliary disease—Mycophenolate mofetil—systemic lupus erythematosus	0.000388	0.00346	CcSEcCtD
Rilpivirine—Nausea—Dapsone—systemic lupus erythematosus	0.000387	0.00345	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic lupus erythematosus	0.000382	0.0034	CcSEcCtD
Rilpivirine—SLCO1B3—Transport of organic anions—ALB—systemic lupus erythematosus	0.000379	0.024	CbGpPWpGaD
Rilpivirine—Urinary tract disorder—Cyclosporine—systemic lupus erythematosus	0.000373	0.00332	CcSEcCtD
Rilpivirine—Urethral disorder—Cyclosporine—systemic lupus erythematosus	0.00037	0.0033	CcSEcCtD
Rilpivirine—Infection—Azathioprine—systemic lupus erythematosus	0.000366	0.00326	CcSEcCtD
Rilpivirine—Urinary tract disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000364	0.00324	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptors—NR3C1—systemic lupus erythematosus	0.000362	0.0229	CbGpPWpGaD
Rilpivirine—Anxiety—Leflunomide—systemic lupus erythematosus	0.000362	0.00322	CcSEcCtD
Rilpivirine—Urethral disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000361	0.00322	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic lupus erythematosus	0.00036	0.00321	CcSEcCtD
Rilpivirine—Skin disorder—Azathioprine—systemic lupus erythematosus	0.000358	0.00319	CcSEcCtD
Rilpivirine—Dry mouth—Leflunomide—systemic lupus erythematosus	0.000355	0.00316	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptor transcription pathway—RXRA—systemic lupus erythematosus	0.000351	0.0222	CbGpPWpGaD
Rilpivirine—Infection—Leflunomide—systemic lupus erythematosus	0.000346	0.00308	CcSEcCtD
Rilpivirine—Nervous system disorder—Leflunomide—systemic lupus erythematosus	0.000341	0.00304	CcSEcCtD
Rilpivirine—Skin disorder—Leflunomide—systemic lupus erythematosus	0.000338	0.00301	CcSEcCtD
Rilpivirine—CYP2B6—lymphoid tissue—systemic lupus erythematosus	0.000336	0.0183	CbGeAlD
Rilpivirine—SLCO1B1—Recycling of bile acids and salts—RXRA—systemic lupus erythematosus	0.000332	0.021	CbGpPWpGaD
Rilpivirine—ABCG2—bone marrow—systemic lupus erythematosus	0.000332	0.0181	CbGeAlD
Rilpivirine—Mental disorder—Cyclosporine—systemic lupus erythematosus	0.000331	0.00295	CcSEcCtD
Rilpivirine—Malnutrition—Cyclosporine—systemic lupus erythematosus	0.000329	0.00293	CcSEcCtD
Rilpivirine—CYP2B6—Liver X Receptor Pathway—RXRA—systemic lupus erythematosus	0.000329	0.0208	CbGpPWpGaD
Rilpivirine—Mental disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000323	0.00288	CcSEcCtD
Rilpivirine—Malnutrition—Mycophenolate mofetil—systemic lupus erythematosus	0.000321	0.00286	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Prednisone—systemic lupus erythematosus	0.000319	0.00284	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Azathioprine—systemic lupus erythematosus	0.000318	0.00283	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptor transcription pathway—VDR—systemic lupus erythematosus	0.000318	0.0201	CbGpPWpGaD
Rilpivirine—Insomnia—Leflunomide—systemic lupus erythematosus	0.000315	0.0028	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000306	0.0194	CbGpPWpGaD
Rilpivirine—Immune system disorder—Hydrocortisone—systemic lupus erythematosus	0.000303	0.0027	CcSEcCtD
Rilpivirine—Decreased appetite—Leflunomide—systemic lupus erythematosus	0.000302	0.00269	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Azathioprine—systemic lupus erythematosus	0.000301	0.00268	CcSEcCtD
Rilpivirine—ABCG2—lung—systemic lupus erythematosus	0.000301	0.0164	CbGeAlD
Rilpivirine—Gastrointestinal disorder—Leflunomide—systemic lupus erythematosus	0.0003	0.00268	CcSEcCtD
Rilpivirine—Fatigue—Leflunomide—systemic lupus erythematosus	0.0003	0.00267	CcSEcCtD
Rilpivirine—CYP3A4—kidney—systemic lupus erythematosus	0.000296	0.0161	CbGeAlD
Rilpivirine—Mental disorder—Hydrocortisone—systemic lupus erythematosus	0.000294	0.00262	CcSEcCtD
Rilpivirine—Malnutrition—Hydrocortisone—systemic lupus erythematosus	0.000292	0.0026	CcSEcCtD
Rilpivirine—Abdominal pain—Azathioprine—systemic lupus erythematosus	0.000291	0.00259	CcSEcCtD
Rilpivirine—CYP1A2—lung—systemic lupus erythematosus	0.000289	0.0158	CbGeAlD
Rilpivirine—SLCO1B1—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000287	0.0181	CbGpPWpGaD
Rilpivirine—NR1I2—Nuclear Receptor transcription pathway—NR3C1—systemic lupus erythematosus	0.000286	0.0181	CbGpPWpGaD
Rilpivirine—Immune system disorder—Methylprednisolone—systemic lupus erythematosus	0.000285	0.00254	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Leflunomide—systemic lupus erythematosus	0.000284	0.00253	CcSEcCtD
Rilpivirine—SLCO1B3—Recycling of bile acids and salts—ALB—systemic lupus erythematosus	0.000281	0.0178	CbGpPWpGaD
Rilpivirine—NR1I2—Nuclear Receptors—PPARG—systemic lupus erythematosus	0.00028	0.0177	CbGpPWpGaD
Rilpivirine—Anxiety—Cyclosporine—systemic lupus erythematosus	0.000279	0.00249	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—systemic lupus erythematosus	0.000278	0.00248	CcSEcCtD
Rilpivirine—Depression—Prednisone—systemic lupus erythematosus	0.000278	0.00247	CcSEcCtD
Rilpivirine—CYP2B6—lung—systemic lupus erythematosus	0.000277	0.0151	CbGeAlD
Rilpivirine—Mental disorder—Methylprednisolone—systemic lupus erythematosus	0.000276	0.00246	CcSEcCtD
Rilpivirine—Abdominal pain—Leflunomide—systemic lupus erythematosus	0.000275	0.00245	CcSEcCtD
Rilpivirine—Malnutrition—Methylprednisolone—systemic lupus erythematosus	0.000275	0.00245	CcSEcCtD
Rilpivirine—Dry mouth—Cyclosporine—systemic lupus erythematosus	0.000274	0.00244	CcSEcCtD
Rilpivirine—Anxiety—Mycophenolate mofetil—systemic lupus erythematosus	0.000272	0.00243	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic lupus erythematosus	0.000271	0.00242	CcSEcCtD
Rilpivirine—Dry mouth—Mycophenolate mofetil—systemic lupus erythematosus	0.000267	0.00238	CcSEcCtD
Rilpivirine—Infection—Cyclosporine—systemic lupus erythematosus	0.000267	0.00238	CcSEcCtD
Rilpivirine—Nervous system disorder—Cyclosporine—systemic lupus erythematosus	0.000263	0.00235	CcSEcCtD
Rilpivirine—Skin disorder—Cyclosporine—systemic lupus erythematosus	0.000261	0.00232	CcSEcCtD
Rilpivirine—Infection—Mycophenolate mofetil—systemic lupus erythematosus	0.00026	0.00232	CcSEcCtD
Rilpivirine—SLCO1B3—Bile acid and bile salt metabolism—RXRA—systemic lupus erythematosus	0.000259	0.0164	CbGpPWpGaD
Rilpivirine—CYP2B6—nervous system—systemic lupus erythematosus	0.000257	0.014	CbGeAlD
Rilpivirine—Nervous system disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000257	0.00229	CcSEcCtD
Rilpivirine—SLCO1B1—Transport of organic anions—ALB—systemic lupus erythematosus	0.000255	0.0161	CbGpPWpGaD
Rilpivirine—Skin disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000254	0.00227	CcSEcCtD
Rilpivirine—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.000252	0.00225	CcSEcCtD
Rilpivirine—Abdominal discomfort—Methotrexate—systemic lupus erythematosus	0.00025	0.00223	CcSEcCtD
Rilpivirine—Asthenia—Leflunomide—systemic lupus erythematosus	0.00025	0.00222	CcSEcCtD
Rilpivirine—Anxiety—Hydrocortisone—systemic lupus erythematosus	0.000248	0.00221	CcSEcCtD
Rilpivirine—CYP2B6—central nervous system—systemic lupus erythematosus	0.000247	0.0135	CbGeAlD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—systemic lupus erythematosus	0.000247	0.0022	CcSEcCtD
Rilpivirine—Dizziness—Azathioprine—systemic lupus erythematosus	0.000244	0.00217	CcSEcCtD
Rilpivirine—Insomnia—Cyclosporine—systemic lupus erythematosus	0.000243	0.00216	CcSEcCtD
Rilpivirine—Somnolence—Cyclosporine—systemic lupus erythematosus	0.000239	0.00213	CcSEcCtD
Rilpivirine—ABCG2—HIF-2-alpha transcription factor network—ETS1—systemic lupus erythematosus	0.000239	0.0151	CbGpPWpGaD
Rilpivirine—ABCB1—nephron tubule—systemic lupus erythematosus	0.000238	0.013	CbGeAlD
Rilpivirine—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.000238	0.00212	CcSEcCtD
Rilpivirine—Infection—Hydrocortisone—systemic lupus erythematosus	0.000237	0.00211	CcSEcCtD
Rilpivirine—Insomnia—Mycophenolate mofetil—systemic lupus erythematosus	0.000237	0.00211	CcSEcCtD
Rilpivirine—Vomiting—Azathioprine—systemic lupus erythematosus	0.000234	0.00209	CcSEcCtD
Rilpivirine—Nervous system disorder—Hydrocortisone—systemic lupus erythematosus	0.000234	0.00208	CcSEcCtD
Rilpivirine—Decreased appetite—Cyclosporine—systemic lupus erythematosus	0.000233	0.00208	CcSEcCtD
Rilpivirine—Anxiety—Methylprednisolone—systemic lupus erythematosus	0.000233	0.00208	CcSEcCtD
Rilpivirine—Somnolence—Mycophenolate mofetil—systemic lupus erythematosus	0.000233	0.00207	CcSEcCtD
Rilpivirine—Rash—Azathioprine—systemic lupus erythematosus	0.000232	0.00207	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	0.000232	0.00207	CcSEcCtD
Rilpivirine—Dermatitis—Azathioprine—systemic lupus erythematosus	0.000232	0.00207	CcSEcCtD
Rilpivirine—Depression—Methotrexate—systemic lupus erythematosus	0.000232	0.00207	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.000232	0.00206	CcSEcCtD
Rilpivirine—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.000232	0.00206	CcSEcCtD
Rilpivirine—Fatigue—Cyclosporine—systemic lupus erythematosus	0.000231	0.00206	CcSEcCtD
Rilpivirine—Headache—Azathioprine—systemic lupus erythematosus	0.000231	0.00206	CcSEcCtD
Rilpivirine—Dizziness—Leflunomide—systemic lupus erythematosus	0.00023	0.00205	CcSEcCtD
Rilpivirine—Dry mouth—Triamcinolone—systemic lupus erythematosus	0.000229	0.00204	CcSEcCtD
Rilpivirine—Renal failure—Methotrexate—systemic lupus erythematosus	0.000229	0.00204	CcSEcCtD
Rilpivirine—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	0.000228	0.00203	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000226	0.00201	CcSEcCtD
Rilpivirine—Immune system disorder—Prednisone—systemic lupus erythematosus	0.000226	0.00201	CcSEcCtD
Rilpivirine—ABCB1—Allograft Rejection—IL21—systemic lupus erythematosus	0.000224	0.0141	CbGpPWpGaD
Rilpivirine—Infection—Triamcinolone—systemic lupus erythematosus	0.000223	0.00199	CcSEcCtD
Rilpivirine—Infection—Methylprednisolone—systemic lupus erythematosus	0.000223	0.00198	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptor transcription pathway—PPARG—systemic lupus erythematosus	0.000221	0.014	CbGpPWpGaD
Rilpivirine—Vomiting—Leflunomide—systemic lupus erythematosus	0.000221	0.00197	CcSEcCtD
Rilpivirine—Insomnia—Prednisolone—systemic lupus erythematosus	0.000221	0.00197	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	0.00022	0.00196	CcSEcCtD
Rilpivirine—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.00022	0.00196	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.00022	0.00196	CcSEcCtD
Rilpivirine—Rash—Leflunomide—systemic lupus erythematosus	0.000219	0.00195	CcSEcCtD
Rilpivirine—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000219	0.00195	CcSEcCtD
Rilpivirine—Mental disorder—Prednisone—systemic lupus erythematosus	0.000219	0.00195	CcSEcCtD
Rilpivirine—Nausea—Azathioprine—systemic lupus erythematosus	0.000219	0.00195	CcSEcCtD
Rilpivirine—Headache—Leflunomide—systemic lupus erythematosus	0.000218	0.00194	CcSEcCtD
Rilpivirine—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000218	0.00194	CcSEcCtD
Rilpivirine—Malnutrition—Prednisone—systemic lupus erythematosus	0.000218	0.00194	CcSEcCtD
Rilpivirine—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.000216	0.00192	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000214	0.00191	CcSEcCtD
Rilpivirine—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000212	0.00189	CcSEcCtD
Rilpivirine—Anxiety—Betamethasone—systemic lupus erythematosus	0.000212	0.00189	CcSEcCtD
Rilpivirine—Anxiety—Dexamethasone—systemic lupus erythematosus	0.000212	0.00189	CcSEcCtD
Rilpivirine—ABCB1—kidney—systemic lupus erythematosus	0.000209	0.0114	CbGeAlD
Rilpivirine—SLCO1B3—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000209	0.0132	CbGpPWpGaD
Rilpivirine—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000207	0.00185	CcSEcCtD
Rilpivirine—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000207	0.00184	CcSEcCtD
Rilpivirine—Nausea—Leflunomide—systemic lupus erythematosus	0.000207	0.00184	CcSEcCtD
Rilpivirine—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	0.000206	0.00184	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000206	0.00184	CcSEcCtD
Rilpivirine—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000206	0.00183	CcSEcCtD
Rilpivirine—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000205	0.00182	CcSEcCtD
Rilpivirine—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000204	0.0111	CbGeAlD
Rilpivirine—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000203	0.00181	CcSEcCtD
Rilpivirine—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000203	0.00181	CcSEcCtD
Rilpivirine—Infection—Dexamethasone—systemic lupus erythematosus	0.000203	0.0018	CcSEcCtD
Rilpivirine—Infection—Betamethasone—systemic lupus erythematosus	0.000203	0.0018	CcSEcCtD
Rilpivirine—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.0002	0.00178	CcSEcCtD
Rilpivirine—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.0002	0.00178	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000195	0.00174	CcSEcCtD
Rilpivirine—CYP3A4—nervous system—systemic lupus erythematosus	0.000194	0.0106	CbGeAlD
Rilpivirine—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000194	0.00173	CcSEcCtD
Rilpivirine—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000193	0.00172	CcSEcCtD
Rilpivirine—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000193	0.00172	CcSEcCtD
Rilpivirine—SLCO1B1—Recycling of bile acids and salts—ALB—systemic lupus erythematosus	0.000189	0.0119	CbGpPWpGaD
Rilpivirine—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.000189	0.00168	CcSEcCtD
Rilpivirine—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000189	0.00168	CcSEcCtD
Rilpivirine—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000188	0.00167	CcSEcCtD
Rilpivirine—CYP3A4—central nervous system—systemic lupus erythematosus	0.000187	0.0102	CbGeAlD
Rilpivirine—Anxiety—Prednisone—systemic lupus erythematosus	0.000185	0.00164	CcSEcCtD
Rilpivirine—Insomnia—Betamethasone—systemic lupus erythematosus	0.000184	0.00164	CcSEcCtD
Rilpivirine—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000184	0.00164	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000184	0.00164	CcSEcCtD
Rilpivirine—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000184	0.00164	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000183	0.00163	CcSEcCtD
Rilpivirine—Mental disorder—Methotrexate—systemic lupus erythematosus	0.000183	0.00163	CcSEcCtD
Rilpivirine—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000182	0.00162	CcSEcCtD
Rilpivirine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—LYN—systemic lupus erythematosus	0.000182	0.0115	CbGpPWpGaD
Rilpivirine—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.00018	0.0098	CbGeAlD
Rilpivirine—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000179	0.0016	CcSEcCtD
Rilpivirine—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000178	0.00158	CcSEcCtD
Rilpivirine—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000177	0.00158	CcSEcCtD
Rilpivirine—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000177	0.00158	CcSEcCtD
Rilpivirine—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000177	0.00158	CcSEcCtD
Rilpivirine—Infection—Prednisone—systemic lupus erythematosus	0.000176	0.00157	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000176	0.00157	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000176	0.00157	CcSEcCtD
Rilpivirine—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000176	0.00157	CcSEcCtD
Rilpivirine—Fatigue—Betamethasone—systemic lupus erythematosus	0.000176	0.00157	CcSEcCtD
Rilpivirine—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000174	0.00155	CcSEcCtD
Rilpivirine—SLCO1B1—Bile acid and bile salt metabolism—RXRA—systemic lupus erythematosus	0.000174	0.011	CbGpPWpGaD
Rilpivirine—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000173	0.00154	CcSEcCtD
Rilpivirine—Skin disorder—Prednisone—systemic lupus erythematosus	0.000172	0.00154	CcSEcCtD
Rilpivirine—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000171	0.00153	CcSEcCtD
Rilpivirine—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000171	0.00152	CcSEcCtD
Rilpivirine—Rash—Cyclosporine—systemic lupus erythematosus	0.000169	0.00151	CcSEcCtD
Rilpivirine—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000169	0.00151	CcSEcCtD
Rilpivirine—Headache—Cyclosporine—systemic lupus erythematosus	0.000168	0.0015	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000167	0.00149	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000167	0.00149	CcSEcCtD
Rilpivirine—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000167	0.00148	CcSEcCtD
Rilpivirine—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000165	0.00147	CcSEcCtD
Rilpivirine—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000165	0.00147	CcSEcCtD
Rilpivirine—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000164	0.00146	CcSEcCtD
Rilpivirine—ABCB1—bone marrow—systemic lupus erythematosus	0.000164	0.00893	CbGeAlD
Rilpivirine—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000163	0.00145	CcSEcCtD
Rilpivirine—Dizziness—Prednisolone—systemic lupus erythematosus	0.000162	0.00144	CcSEcCtD
Rilpivirine—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000161	0.00144	CcSEcCtD
Rilpivirine—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000161	0.00144	CcSEcCtD
Rilpivirine—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000161	0.00144	CcSEcCtD
Rilpivirine—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000161	0.00143	CcSEcCtD
Rilpivirine—Insomnia—Prednisone—systemic lupus erythematosus	0.000161	0.00143	CcSEcCtD
Rilpivirine—Nausea—Cyclosporine—systemic lupus erythematosus	0.000159	0.00142	CcSEcCtD
Rilpivirine—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000158	0.00141	CcSEcCtD
Rilpivirine—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000156	0.00139	CcSEcCtD
Rilpivirine—Decreased appetite—Prednisone—systemic lupus erythematosus	0.000154	0.00137	CcSEcCtD
Rilpivirine—Rash—Prednisolone—systemic lupus erythematosus	0.000154	0.00137	CcSEcCtD
Rilpivirine—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000154	0.00137	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000154	0.00137	CcSEcCtD
Rilpivirine—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000153	0.00137	CcSEcCtD
Rilpivirine—Fatigue—Prednisone—systemic lupus erythematosus	0.000153	0.00136	CcSEcCtD
Rilpivirine—Headache—Prednisolone—systemic lupus erythematosus	0.000153	0.00136	CcSEcCtD
Rilpivirine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—systemic lupus erythematosus	0.000152	0.00963	CbGpPWpGaD
Rilpivirine—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000152	0.00135	CcSEcCtD
Rilpivirine—Rash—Hydrocortisone—systemic lupus erythematosus	0.00015	0.00134	CcSEcCtD
Rilpivirine—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.00015	0.00134	CcSEcCtD
Rilpivirine—Headache—Hydrocortisone—systemic lupus erythematosus	0.000149	0.00133	CcSEcCtD
Rilpivirine—CYP3A4—Liver X Receptor Pathway—RXRA—systemic lupus erythematosus	0.000149	0.00945	CbGpPWpGaD
Rilpivirine—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000149	0.00132	CcSEcCtD
Rilpivirine—ABCB1—lung—systemic lupus erythematosus	0.000148	0.00809	CbGeAlD
Rilpivirine—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000148	0.00132	CcSEcCtD
Rilpivirine—Infection—Methotrexate—systemic lupus erythematosus	0.000147	0.00131	CcSEcCtD
Rilpivirine—SLCO1B3—Bile acid and bile salt metabolism—ALB—systemic lupus erythematosus	0.000147	0.00929	CbGpPWpGaD
Rilpivirine—Asthenia—Betamethasone—systemic lupus erythematosus	0.000146	0.0013	CcSEcCtD
Rilpivirine—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000146	0.0013	CcSEcCtD
Rilpivirine—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000145	0.0013	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000145	0.00129	CcSEcCtD
Rilpivirine—Nausea—Prednisolone—systemic lupus erythematosus	0.000145	0.00129	CcSEcCtD
Rilpivirine—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000144	0.00128	CcSEcCtD
Rilpivirine—ABCB1—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000144	0.00909	CbGpPWpGaD
Rilpivirine—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000143	0.00127	CcSEcCtD
Rilpivirine—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000143	0.00127	CcSEcCtD
Rilpivirine—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000142	0.00126	CcSEcCtD
Rilpivirine—Rash—Triamcinolone—systemic lupus erythematosus	0.000142	0.00126	CcSEcCtD
Rilpivirine—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000142	0.00126	CcSEcCtD
Rilpivirine—Rash—Methylprednisolone—systemic lupus erythematosus	0.000141	0.00126	CcSEcCtD
Rilpivirine—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000141	0.00126	CcSEcCtD
Rilpivirine—Headache—Triamcinolone—systemic lupus erythematosus	0.000141	0.00125	CcSEcCtD
Rilpivirine—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—ALB—systemic lupus erythematosus	0.000141	0.0089	CbGpPWpGaD
Rilpivirine—Headache—Methylprednisolone—systemic lupus erythematosus	0.00014	0.00125	CcSEcCtD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—ETS1—systemic lupus erythematosus	0.00014	0.00888	CbGpPWpGaD
Rilpivirine—SLCO1B1—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.00014	0.00888	CbGpPWpGaD
Rilpivirine—Abdominal pain—Prednisone—systemic lupus erythematosus	0.00014	0.00125	CcSEcCtD
Rilpivirine—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000139	0.00124	CcSEcCtD
Rilpivirine—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000139	0.00124	CcSEcCtD
Rilpivirine—ABCB1—nervous system—systemic lupus erythematosus	0.000137	0.00749	CbGeAlD
Rilpivirine—Dizziness—Betamethasone—systemic lupus erythematosus	0.000135	0.0012	CcSEcCtD
Rilpivirine—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000135	0.0012	CcSEcCtD
Rilpivirine—Insomnia—Methotrexate—systemic lupus erythematosus	0.000134	0.0012	CcSEcCtD
Rilpivirine—Nausea—Triamcinolone—systemic lupus erythematosus	0.000133	0.00119	CcSEcCtD
Rilpivirine—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000133	0.00119	CcSEcCtD
Rilpivirine—ABCB1—central nervous system—systemic lupus erythematosus	0.000132	0.00721	CbGeAlD
Rilpivirine—Somnolence—Methotrexate—systemic lupus erythematosus	0.000132	0.00118	CcSEcCtD
Rilpivirine—Vomiting—Dexamethasone—systemic lupus erythematosus	0.00013	0.00115	CcSEcCtD
Rilpivirine—Vomiting—Betamethasone—systemic lupus erythematosus	0.00013	0.00115	CcSEcCtD
Rilpivirine—CYP2B6—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.00013	0.0082	CbGpPWpGaD
Rilpivirine—Decreased appetite—Methotrexate—systemic lupus erythematosus	0.000129	0.00115	CcSEcCtD
Rilpivirine—Rash—Betamethasone—systemic lupus erythematosus	0.000129	0.00115	CcSEcCtD
Rilpivirine—Rash—Dexamethasone—systemic lupus erythematosus	0.000129	0.00115	CcSEcCtD
Rilpivirine—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000128	0.00114	CcSEcCtD
Rilpivirine—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000128	0.00114	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000128	0.00114	CcSEcCtD
Rilpivirine—Fatigue—Methotrexate—systemic lupus erythematosus	0.000128	0.00114	CcSEcCtD
Rilpivirine—Headache—Betamethasone—systemic lupus erythematosus	0.000128	0.00114	CcSEcCtD
Rilpivirine—Headache—Dexamethasone—systemic lupus erythematosus	0.000128	0.00114	CcSEcCtD
Rilpivirine—Asthenia—Prednisone—systemic lupus erythematosus	0.000127	0.00113	CcSEcCtD
Rilpivirine—Diarrhoea—Prednisone—systemic lupus erythematosus	0.000121	0.00108	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	0.000121	0.00108	CcSEcCtD
Rilpivirine—Nausea—Betamethasone—systemic lupus erythematosus	0.000121	0.00108	CcSEcCtD
Rilpivirine—Nausea—Dexamethasone—systemic lupus erythematosus	0.000121	0.00108	CcSEcCtD
Rilpivirine—Dizziness—Prednisone—systemic lupus erythematosus	0.000117	0.00105	CcSEcCtD
Rilpivirine—Abdominal pain—Methotrexate—systemic lupus erythematosus	0.000117	0.00104	CcSEcCtD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—CXCL12—systemic lupus erythematosus	0.000115	0.00729	CbGpPWpGaD
Rilpivirine—Vomiting—Prednisone—systemic lupus erythematosus	0.000113	0.00101	CcSEcCtD
Rilpivirine—Rash—Prednisone—systemic lupus erythematosus	0.000112	0.000997	CcSEcCtD
Rilpivirine—Dermatitis—Prednisone—systemic lupus erythematosus	0.000112	0.000996	CcSEcCtD
Rilpivirine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000112	0.00708	CbGpPWpGaD
Rilpivirine—Headache—Prednisone—systemic lupus erythematosus	0.000111	0.000991	CcSEcCtD
Rilpivirine—ABCB1—Allograft Rejection—C4A—systemic lupus erythematosus	0.000109	0.00691	CbGpPWpGaD
Rilpivirine—Asthenia—Methotrexate—systemic lupus erythematosus	0.000106	0.000948	CcSEcCtD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000106	0.00672	CbGpPWpGaD
Rilpivirine—Nausea—Prednisone—systemic lupus erythematosus	0.000105	0.000939	CcSEcCtD
Rilpivirine—Diarrhoea—Methotrexate—systemic lupus erythematosus	0.000102	0.000904	CcSEcCtD
Rilpivirine—NR1I2—Gene Expression—SNRPD1—systemic lupus erythematosus	0.0001	0.00634	CbGpPWpGaD
Rilpivirine—SLCO1B1—Bile acid and bile salt metabolism—ALB—systemic lupus erythematosus	9.86e-05	0.00624	CbGpPWpGaD
Rilpivirine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—LYN—systemic lupus erythematosus	9.82e-05	0.00621	CbGpPWpGaD
Rilpivirine—Dizziness—Methotrexate—systemic lupus erythematosus	9.81e-05	0.000874	CcSEcCtD
Rilpivirine—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	9.79e-05	0.0062	CbGpPWpGaD
Rilpivirine—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	9.56e-05	0.00605	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—systemic lupus erythematosus	9.45e-05	0.00598	CbGpPWpGaD
Rilpivirine—Vomiting—Methotrexate—systemic lupus erythematosus	9.43e-05	0.00084	CcSEcCtD
Rilpivirine—Rash—Methotrexate—systemic lupus erythematosus	9.35e-05	0.000833	CcSEcCtD
Rilpivirine—Dermatitis—Methotrexate—systemic lupus erythematosus	9.35e-05	0.000833	CcSEcCtD
Rilpivirine—Headache—Methotrexate—systemic lupus erythematosus	9.29e-05	0.000828	CcSEcCtD
Rilpivirine—NR1I2—Gene Expression—MTA2—systemic lupus erythematosus	9.06e-05	0.00573	CbGpPWpGaD
Rilpivirine—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—systemic lupus erythematosus	8.94e-05	0.00565	CbGpPWpGaD
Rilpivirine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	8.85e-05	0.0056	CbGpPWpGaD
Rilpivirine—Nausea—Methotrexate—systemic lupus erythematosus	8.81e-05	0.000785	CcSEcCtD
Rilpivirine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	8.25e-05	0.00522	CbGpPWpGaD
Rilpivirine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—systemic lupus erythematosus	8.22e-05	0.0052	CbGpPWpGaD
Rilpivirine—CYP2B6—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	7.84e-05	0.00496	CbGpPWpGaD
Rilpivirine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	7.79e-05	0.00493	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—FOXP3—systemic lupus erythematosus	7.64e-05	0.00483	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—ETS1—systemic lupus erythematosus	7.59e-05	0.0048	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	7.13e-05	0.00451	CbGpPWpGaD
Rilpivirine—ABCG2—HIF-2-alpha transcription factor network—EP300—systemic lupus erythematosus	6.96e-05	0.0044	CbGpPWpGaD
Rilpivirine—NR1I2—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	6.91e-05	0.00437	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—systemic lupus erythematosus	6.88e-05	0.00435	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	6.6e-05	0.00418	CbGpPWpGaD
Rilpivirine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—systemic lupus erythematosus	6.59e-05	0.00417	CbGpPWpGaD
Rilpivirine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	6.58e-05	0.00417	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUNB—systemic lupus erythematosus	6.51e-05	0.00412	CbGpPWpGaD
Rilpivirine—CYP2B6—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	6.35e-05	0.00402	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—CXCL12—systemic lupus erythematosus	6.23e-05	0.00394	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—TNFSF13—systemic lupus erythematosus	6.12e-05	0.00387	CbGpPWpGaD
Rilpivirine—CYP1A2—Phase II conjugation—NAT2—systemic lupus erythematosus	6.06e-05	0.00383	CbGpPWpGaD
Rilpivirine—NR1I2—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	6.06e-05	0.00383	CbGpPWpGaD
Rilpivirine—CYP2B6—Biological oxidations—NAT2—systemic lupus erythematosus	6.02e-05	0.00381	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—IL17A—systemic lupus erythematosus	6.01e-05	0.0038	CbGpPWpGaD
Rilpivirine—CYP2B6—Metapathway biotransformation—NAT2—systemic lupus erythematosus	5.94e-05	0.00376	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—SNRPB—systemic lupus erythematosus	5.92e-05	0.00375	CbGpPWpGaD
Rilpivirine—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	5.92e-05	0.00375	CbGpPWpGaD
Rilpivirine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	5.91e-05	0.00374	CbGpPWpGaD
Rilpivirine—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	5.89e-05	0.00373	CbGpPWpGaD
Rilpivirine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	5.75e-05	0.00364	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—IL12B—systemic lupus erythematosus	5.59e-05	0.00354	CbGpPWpGaD
Rilpivirine—NR1I2—Generic Transcription Pathway—VDR—systemic lupus erythematosus	5.49e-05	0.00347	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—CXCL12—systemic lupus erythematosus	5.39e-05	0.00341	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—CD40—systemic lupus erythematosus	5.33e-05	0.00337	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—CTLA4—systemic lupus erythematosus	5.25e-05	0.00333	CbGpPWpGaD
Rilpivirine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	5.08e-05	0.00322	CbGpPWpGaD
Rilpivirine—NR1I2—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	4.94e-05	0.00312	CbGpPWpGaD
Rilpivirine—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	4.8e-05	0.00304	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—HIST2H2AC—systemic lupus erythematosus	4.76e-05	0.00301	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—HLA-DQA1—systemic lupus erythematosus	4.63e-05	0.00293	CbGpPWpGaD
Rilpivirine—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	4.61e-05	0.00292	CbGpPWpGaD
Rilpivirine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	4.59e-05	0.0029	CbGpPWpGaD
Rilpivirine—CYP2C19—Biological oxidations—NAT2—systemic lupus erythematosus	4.55e-05	0.00288	CbGpPWpGaD
Rilpivirine—CYP2C19—Metapathway biotransformation—NAT2—systemic lupus erythematosus	4.49e-05	0.00284	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—HLA-DQB1—systemic lupus erythematosus	4.33e-05	0.00274	CbGpPWpGaD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	4.09e-05	0.00259	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—CD40LG—systemic lupus erythematosus	4.09e-05	0.00259	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—IL10—systemic lupus erythematosus	4.09e-05	0.00259	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—IL4—systemic lupus erythematosus	3.98e-05	0.00252	CbGpPWpGaD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	3.88e-05	0.00245	CbGpPWpGaD
Rilpivirine—NR1I2—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	3.82e-05	0.00242	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—FASLG—systemic lupus erythematosus	3.8e-05	0.0024	CbGpPWpGaD
Rilpivirine—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	3.74e-05	0.00237	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—FAS—systemic lupus erythematosus	3.66e-05	0.00232	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—IL2RA—systemic lupus erythematosus	3.64e-05	0.0023	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—C3—systemic lupus erythematosus	3.61e-05	0.00229	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	3.57e-05	0.00226	CbGpPWpGaD
Rilpivirine—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	3.56e-05	0.00225	CbGpPWpGaD
Rilpivirine—CYP1A2—Biological oxidations—NAT2—systemic lupus erythematosus	3.54e-05	0.00224	CbGpPWpGaD
Rilpivirine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	3.54e-05	0.00224	CbGpPWpGaD
Rilpivirine—CYP1A2—Metapathway biotransformation—NAT2—systemic lupus erythematosus	3.5e-05	0.00221	CbGpPWpGaD
Rilpivirine—CYP2C19—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	3.4e-05	0.00215	CbGpPWpGaD
Rilpivirine—CYP2B6—Biological oxidations—RXRA—systemic lupus erythematosus	3.37e-05	0.00214	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—JUNB—systemic lupus erythematosus	3.33e-05	0.00211	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—HLA-DRB1—systemic lupus erythematosus	3.29e-05	0.00208	CbGpPWpGaD
Rilpivirine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	3.2e-05	0.00202	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—CD80—systemic lupus erythematosus	3.04e-05	0.00192	CbGpPWpGaD
Rilpivirine—SLCO1B3—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	3.02e-05	0.00191	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—systemic lupus erythematosus	2.96e-05	0.00187	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—RXRA—systemic lupus erythematosus	2.92e-05	0.00185	CbGpPWpGaD
Rilpivirine—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	2.89e-05	0.00183	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.84e-05	0.0018	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—systemic lupus erythematosus	2.83e-05	0.00179	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	2.77e-05	0.00175	CbGpPWpGaD
Rilpivirine—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	2.74e-05	0.00173	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	2.7e-05	0.00171	CbGpPWpGaD
Rilpivirine—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	2.7e-05	0.00171	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	2.68e-05	0.0017	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	2.68e-05	0.0017	CbGpPWpGaD
Rilpivirine—CYP1A2—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	2.65e-05	0.00168	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—VDR—systemic lupus erythematosus	2.64e-05	0.00167	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	2.63e-05	0.00166	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	2.61e-05	0.00165	CbGpPWpGaD
Rilpivirine—CYP2C19—Biological oxidations—RXRA—systemic lupus erythematosus	2.55e-05	0.00161	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	2.48e-05	0.00157	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—IFNG—systemic lupus erythematosus	2.4e-05	0.00152	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—NR3C1—systemic lupus erythematosus	2.38e-05	0.0015	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	2.36e-05	0.00149	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	2.36e-05	0.00149	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	2.29e-05	0.00145	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—NAT2—systemic lupus erythematosus	2.26e-05	0.00143	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	2.23e-05	0.00141	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	2.21e-05	0.0014	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—IL2—systemic lupus erythematosus	2.14e-05	0.00135	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	2.1e-05	0.00133	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	2.05e-05	0.0013	CbGpPWpGaD
Rilpivirine—SLCO1B1—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	2.03e-05	0.00128	CbGpPWpGaD
Rilpivirine—CYP1A2—Biological oxidations—RXRA—systemic lupus erythematosus	1.99e-05	0.00126	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	1.91e-05	0.00121	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	1.91e-05	0.00121	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.91e-05	0.00121	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	1.87e-05	0.00119	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—PPARG—systemic lupus erythematosus	1.84e-05	0.00117	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.82e-05	0.00115	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—VEGFA—systemic lupus erythematosus	1.81e-05	0.00115	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	1.81e-05	0.00114	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.79e-05	0.00114	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.68e-05	0.00106	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—TGFB1—systemic lupus erythematosus	1.67e-05	0.00105	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.61e-05	0.00102	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—TNF—systemic lupus erythematosus	1.56e-05	0.000984	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.53e-05	0.000971	CbGpPWpGaD
Rilpivirine—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	1.53e-05	0.00097	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—NAT2—systemic lupus erythematosus	1.52e-05	0.00096	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.41e-05	0.000893	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—NAT2—systemic lupus erythematosus	1.4e-05	0.000889	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—RXRA—systemic lupus erythematosus	1.27e-05	0.000801	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.21e-05	0.000763	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.17e-05	0.000743	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	1.14e-05	0.000719	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.08e-05	0.000686	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.08e-05	0.000681	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.03e-05	0.000652	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—NAT2—systemic lupus erythematosus	1.03e-05	0.000651	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	9.94e-06	0.000629	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	9.79e-06	0.00062	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	9.54e-06	0.000604	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	9.48e-06	0.0006	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	9.46e-06	0.000598	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	9.09e-06	0.000575	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	8.96e-06	0.000567	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—RXRA—systemic lupus erythematosus	8.5e-06	0.000538	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	8.22e-06	0.00052	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PPARG—systemic lupus erythematosus	7.99e-06	0.000506	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.89e-06	0.000499	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—RXRA—systemic lupus erythematosus	7.87e-06	0.000498	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—NAT2—systemic lupus erythematosus	7.78e-06	0.000492	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	7.68e-06	0.000486	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	7.63e-06	0.000483	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	7.59e-06	0.000481	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—ALB—systemic lupus erythematosus	7.18e-06	0.000455	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—NOS3—systemic lupus erythematosus	6.87e-06	0.000435	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PTGS2—systemic lupus erythematosus	6.29e-06	0.000398	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	6.18e-06	0.000391	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—NAT2—systemic lupus erythematosus	6.06e-06	0.000384	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—RXRA—systemic lupus erythematosus	5.77e-06	0.000365	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.56e-06	0.000352	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PPARG—systemic lupus erythematosus	5.37e-06	0.00034	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—EP300—systemic lupus erythematosus	5.23e-06	0.000331	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	5.16e-06	0.000327	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PPARG—systemic lupus erythematosus	4.97e-06	0.000315	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.86e-06	0.000308	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—ALB—systemic lupus erythematosus	4.83e-06	0.000305	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.82e-06	0.000305	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	4.68e-06	0.000296	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—NOS3—systemic lupus erythematosus	4.62e-06	0.000292	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—ALB—systemic lupus erythematosus	4.47e-06	0.000283	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—RXRA—systemic lupus erythematosus	4.36e-06	0.000276	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.33e-06	0.000274	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—NOS3—systemic lupus erythematosus	4.28e-06	0.000271	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	4.26e-06	0.000269	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PTGS2—systemic lupus erythematosus	4.22e-06	0.000267	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.05e-06	0.000256	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PTGS2—systemic lupus erythematosus	3.91e-06	0.000247	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.79e-06	0.00024	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PPARG—systemic lupus erythematosus	3.64e-06	0.000231	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—EP300—systemic lupus erythematosus	3.51e-06	0.000222	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	3.4e-06	0.000215	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ALB—systemic lupus erythematosus	3.28e-06	0.000207	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—EP300—systemic lupus erythematosus	3.25e-06	0.000206	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.15e-06	0.000199	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—NOS3—systemic lupus erythematosus	3.13e-06	0.000198	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PTGS2—systemic lupus erythematosus	2.87e-06	0.000181	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PPARG—systemic lupus erythematosus	2.75e-06	0.000174	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	2.69e-06	0.00017	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	2.62e-06	0.000166	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ALB—systemic lupus erythematosus	2.48e-06	0.000157	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ALB—systemic lupus erythematosus	2.42e-06	0.000153	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—EP300—systemic lupus erythematosus	2.38e-06	0.000151	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—NOS3—systemic lupus erythematosus	2.37e-06	0.00015	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	2.31e-06	0.000146	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PTGS2—systemic lupus erythematosus	2.17e-06	0.000137	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	2.15e-06	0.000136	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	2.11e-06	0.000134	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	1.93e-06	0.000122	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	1.85e-06	0.000117	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—EP300—systemic lupus erythematosus	1.8e-06	0.000114	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—EP300—systemic lupus erythematosus	1.76e-06	0.000111	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	1.69e-06	0.000107	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	1.66e-06	0.000105	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	1.49e-06	9.42e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	1.42e-06	9.01e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	1.4e-06	8.88e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	1.3e-06	8.24e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	1.08e-06	6.86e-05	CbGpPWpGaD
